This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cruz-Munoz, W. Articles by Kerbel, R. S. Search for Related Content PubMed PubMed Citation Articles by Cruz-Munoz, W. Articles by Kerbel, R. S.

Development of a Preclinical Model of Spontaneous Human Melanoma Central Nervous System Metastasis

Sunnybrook Health Sciences Centre, Molecular and Cellular Biology Research, Toronto, Ontario, Canada

Requests for reprints: Robert S. Kerbel, Sunnybrook Health Sciences Centre, Molecular and Cellular Biology Research, S-217, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada. Phone: 416-480-5711; Fax: 416-480-5884; E-mail: Robert.Kerbel{at}sri.utoronto.ca.

Key Words: melanoma • spontaneous metastasis • brain • vinblastine • cyclophosphamide • chemotherapy

Metastatic spread of melanoma to the central nervous system (CNS) is associated with dismal prognosis. Preclinical testing of novel therapeutic approaches would be aided by the development of appropriate models of spontaneous CNS metastasis arising from primary tumors. A highly metastatic variant of the WM239A human melanoma cell line, designated 113/6-4L, was generated and used to test the efficacy of long-term, low-dose metronomic cyclophosphamide and vinblastine chemotherapy on advanced established metastatic disease in sites such as liver, lungs, and lymph node. This treatment resulted in control of advanced, systemic disease and prolongation of survival. Among long-term surviving mice, 20% showed the presence of spontaneous brain metastases. Two cell lines (131/4-5B1 and 131/4-5B2) were generated from such metastases, which were found to spontaneously metastasize to brain parenchyma with occasional localization to leptomeninges, after orthotopic transplantation and removal of the primary tumor. The cell lines were found to have increased ability to proliferate in brain-conditioned medium and displayed enhanced adhesion to lung and brain endothelial cells. These findings represent the first report of spontaneous CNS metastases generated from primary tumors of any human cancer in mice, which heritably maintains this phenotype, and as such, the variant cell lines generated should aid studies in the biology and treatment of CNS metastases, especially of melanoma origin. [Cancer Res 2008;68(12):4500–5]

This article has been cited by other articles:

				G. Francia, S. Man, C.-J. Lee, C. R. Lee, P. Xu, M. E. Mossoba, U. Emmenegger, J. A. Medin, and R. S. Kerbel Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2-Positive Human Breast Cancer Xenografts Clin. Cancer Res., October 15, 2009; 15(20): 6358 - 6366. [Abstract] [Full Text] [PDF]

				W. Cruz-Munoz, S. Man, and R. S. Kerbel Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens Clin. Cancer Res., August 1, 2009; 15(15): 4867 - 4874. [Abstract] [Full Text] [PDF]

				R. M. Hoffman Comment re: Preclinical Model of Spontaneous Melanoma Metastasis Cancer Res., January 15, 2009; 69(2): 719 - 719. [Full Text] [PDF]